Global Janus Kinase (JAK) Inhibitors Market 2019 by Company, Regions, Type and Application, Forecast to 2024

  • receipt Report ID : 217659
  • calendar_today Published On: Nov, 2019
  • file_copy Pages: 107
  • list Pharmaceuticals and Healthcare

Scope of the Report:

The global Janus Kinase (JAK) Inhibitors market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Janus Kinase (JAK) Inhibitors.

Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.

This report studies the Janus Kinase (JAK) Inhibitors market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Janus Kinase (JAK) Inhibitors market by product type and applications/end industries.

Market Segment by Companies, this report covers

Astellas Pharma, Inc.

Novartis AG

Eli Lilly and Co.

Incyte Corp.

Pfizer Inc.

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Ruxolitinib

Tofacitinib

Oclacitinib

Baricitinib

Peficitinib

Market Segment by Applications, can be divided into

Autoimmune Disorders

Oncology

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Janus Kinase (JAK) Inhibitors Market Overview

1.1 Product Overview and Scope of Janus Kinase (JAK) Inhibitors

1.2 Classification of Janus Kinase (JAK) Inhibitors by Types

1.2.1 Global Janus Kinase (JAK) Inhibitors Revenue Comparison by Types (2019-2024)

1.2.2 Global Janus Kinase (JAK) Inhibitors Revenue Market Share by Types in 2018

1.2.3 Ruxolitinib

1.2.4 Tofacitinib

1.2.5 Oclacitinib

1.2.6 Baricitinib

1.2.7 Peficitinib

1.3 Global Janus Kinase (JAK) Inhibitors Market by Application

1.3.1 Global Janus Kinase (JAK) Inhibitors Market Size and Market Share Comparison by Applications (2014-2024)

1.3.2 Autoimmune Disorders

1.3.3 Oncology

1.4 Global Janus Kinase (JAK) Inhibitors Market by Regions

1.4.1 Global Janus Kinase (JAK) Inhibitors Market Size (Million USD) Comparison by Regions (2014-2024)

1.4.1 North America (USA, Canada and Mexico) Janus Kinase (JAK) Inhibitors Status and Prospect (2014-2024)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Janus Kinase (JAK) Inhibitors Status and Prospect (2014-2024)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Janus Kinase (JAK) Inhibitors Status and Prospect (2014-2024)

1.4.4 South America (Brazil, Argentina, Colombia) Janus Kinase (JAK) Inhibitors Status and Prospect (2014-2024)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Janus Kinase (JAK) Inhibitors Status and Prospect (2014-2024)

1.5 Global Market Size of Janus Kinase (JAK) Inhibitors (2014-2024)

2 Company Profiles

2.1 Astellas Pharma, Inc.

2.1.1 Business Overview

2.1.2 Janus Kinase (JAK) Inhibitors Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Astellas Pharma, Inc. Janus Kinase (JAK) Inhibitors Revenue, Gross Margin and Market Share (2017-2018)

2.2 Novartis AG

2.2.1 Business Overview

2.2.2 Janus Kinase (JAK) Inhibitors Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Novartis AG Janus Kinase (JAK) Inhibitors Revenue, Gross Margin and Market Share (2017-2018)

2.3 Eli Lilly and Co.

2.3.1 Business Overview

2.3.2 Janus Kinase (JAK) Inhibitors Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Eli Lilly and Co. Janus Kinase (JAK) Inhibitors Revenue, Gross Margin and Market Share (2017-2018)

2.4 Incyte Corp.

2.4.1 Business Overview

2.4.2 Janus Kinase (JAK) Inhibitors Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Incyte Corp. Janus Kinase (JAK) Inhibitors Revenue, Gross Margin and Market Share (2017-2018)

2.5 Pfizer Inc.

2.5.1 Business Overview

2.5.2 Janus Kinase (JAK) Inhibitors Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Pfizer Inc. Janus Kinase (JAK) Inhibitors Revenue, Gross Margin and Market Share (2017-2018)

3 Global Janus Kinase (JAK) Inhibitors Market Competition, by Players

3.1 Global Janus Kinase (JAK) Inhibitors Revenue and Share by Players (2014-2019)

3.2 Market Concentration Rate

3.2.1 Top 5 Janus Kinase (JAK) Inhibitors Players Market Share

3.2.2 Top 10 Janus Kinase (JAK) Inhibitors Players Market Share

3.3 Market Competition Trend

4 Global Janus Kinase (JAK) Inhibitors Market Size by Regions

4.1 Global Janus Kinase (JAK) Inhibitors Revenue and Market Share by Regions

4.2 North America Janus Kinase (JAK) Inhibitors Revenue and Growth Rate (2014-2019)

4.3 Europe Janus Kinase (JAK) Inhibitors Revenue and Growth Rate (2014-2019)

4.4 Asia-Pacific Janus Kinase (JAK) Inhibitors Revenue and Growth Rate (2014-2019)

4.5 South America Janus Kinase (JAK) Inhibitors Revenue and Growth Rate (2014-2019)

4.6 Middle East and Africa Janus Kinase (JAK) Inhibitors Revenue and Growth Rate (2014-2019)

5 North America Janus Kinase (JAK) Inhibitors Revenue by Countries

5.1 North America Janus Kinase (JAK) Inhibitors Revenue by Countries (2014-2019)

5.2 USA Janus Kinase (JAK) Inhibitors Revenue and Growth Rate (2014-2019)

5.3 Canada Janus Kinase (JAK) Inhibitors Revenue and Growth Rate (2014-2019)

5.4 Mexico Janus Kinase (JAK) Inhibitors Revenue and Growth Rate (2014-2019)

6 Europe Janus Kinase (JAK) Inhibitors Revenue by Countries

6.1 Europe Janus Kinase (JAK) Inhibitors Revenue by Countries (2014-2019)

6.2 Germany Janus Kinase (JAK) Inhibitors Revenue and Growth Rate (2014-2019)

6.3 UK Janus Kinase (JAK) Inhibitors Revenue and Growth Rate (2014-2019)

6.4 France Janus Kinase (JAK) Inhibitors Revenue and Growth Rate (2014-2019)

6.5 Russia Janus Kinase (JAK) Inhibitors Revenue and Growth Rate (2014-2019)

6.6 Italy Janus Kinase (JAK) Inhibitors Revenue and Growth Rate (2014-2019)

7 Asia-Pacific Janus Kinase (JAK) Inhibitors Revenue by Countries

7.1 Asia-Pacific Janus Kinase (JAK) Inhibitors Revenue by Countries (2014-2019)

7.2 China Janus Kinase (JAK) Inhibitors Revenue and Growth Rate (2014-2019)

7.3 Japan Janus Kinase (JAK) Inhibitors Revenue and Growth Rate (2014-2019)

7.4 Korea Janus Kinase (JAK) Inhibitors Revenue and Growth Rate (2014-2019)

7.5 India Janus Kinase (JAK) Inhibitors Revenue and Growth Rate (2014-2019)

7.6 Southeast Asia Janus Kinase (JAK) Inhibitors Revenue and Growth Rate (2014-2019)

8 South America Janus Kinase (JAK) Inhibitors Revenue by Countries

8.1 South America Janus Kinase (JAK) Inhibitors Revenue by Countries (2014-2019)

8.2 Brazil Janus Kinase (JAK) Inhibitors Revenue and Growth Rate (2014-2019)

8.3 Argentina Janus Kinase (JAK) Inhibitors Revenue and Growth Rate (2014-2019)

8.4 Colombia Janus Kinase (JAK) Inhibitors Revenue and Growth Rate (2014-2019)

9 Middle East and Africa Revenue Janus Kinase (JAK) Inhibitors by Countries

9.1 Middle East and Africa Janus Kinase (JAK) Inhibitors Revenue by Countries (2014-2019)

9.2 Saudi Arabia Janus Kinase (JAK) Inhibitors Revenue and Growth Rate (2014-2019)

9.3 UAE Janus Kinase (JAK) Inhibitors Revenue and Growth Rate (2014-2019)

9.4 Egypt Janus Kinase (JAK) Inhibitors Revenue and Growth Rate (2014-2019)

9.5 Nigeria Janus Kinase (JAK) Inhibitors Revenue and Growth Rate (2014-2019)

9.6 South Africa Janus Kinase (JAK) Inhibitors Revenue and Growth Rate (2014-2019)

10 Global Janus Kinase (JAK) Inhibitors Market Segment by Type

10.1 Global Janus Kinase (JAK) Inhibitors Revenue and Market Share by Type (2014-2019)

10.2 Global Janus Kinase (JAK) Inhibitors Market Forecast by Type (2019-2024)

10.3 Ruxolitinib Revenue Growth Rate (2014-2024)

10.4 Tofacitinib Revenue Growth Rate (2014-2024)

10.5 Oclacitinib Revenue Growth Rate (2014-2024)

10.6 Baricitinib Revenue Growth Rate (2014-2024)

10.7 Peficitinib Revenue Growth Rate (2014-2024)

11 Global Janus Kinase (JAK) Inhibitors Market Segment by Application

11.1 Global Janus Kinase (JAK) Inhibitors Revenue Market Share by Application (2014-2019)

11.2 Janus Kinase (JAK) Inhibitors Market Forecast by Application (2019-2024)

11.3 Autoimmune Disorders Revenue Growth (2014-2019)

11.4 Oncology Revenue Growth (2014-2019)

12 Global Janus Kinase (JAK) Inhibitors Market Size Forecast (2019-2024)

12.1 Global Janus Kinase (JAK) Inhibitors Market Size Forecast (2019-2024)

12.2 Global Janus Kinase (JAK) Inhibitors Market Forecast by Regions (2019-2024)

12.3 North America Janus Kinase (JAK) Inhibitors Revenue Market Forecast (2019-2024)

12.4 Europe Janus Kinase (JAK) Inhibitors Revenue Market Forecast (2019-2024)

12.5 Asia-Pacific Janus Kinase (JAK) Inhibitors Revenue Market Forecast (2019-2024)

12.6 South America Janus Kinase (JAK) Inhibitors Revenue Market Forecast (2019-2024)

12.7 Middle East and Africa Janus Kinase (JAK) Inhibitors Revenue Market Forecast (2019-2024)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

List of Tables and Figures

Figure Janus Kinase (JAK) Inhibitors Picture

Table Product Specifications of Janus Kinase (JAK) Inhibitors

Table Global Janus Kinase (JAK) Inhibitors and Revenue (Million U

Please fill the form below, to recieve the report sample


+1

Choose License Type

Reach Us

Email us at

sales@mrinsights.biz

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery